We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 04 NOVEMBER 2010
Myriad Genetics Ruling - Human Gene Patents Invalidated in US District Court
Spruson & Ferguson Lawyers
Myriad Genetics patents on two genes linked to breast and ovarian cancer (BRCA1 and BRCA2,) have been struck down in a US District Court ruling – Judge Sweet stating that the patents "are directed to a law of nature and were therefore improperly granted" (Association for Molecular Biology et. al. Vs United States Patent and Trademark Office et. al.; "the Myriad decision"). This is a pivotal case for those operating in the biotech space and will shape the future of gene patenting and the developi
AustraliaIntellectual Property




